[HTML][HTML] Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
S Wei, X Yu - Complementary therapies in medicine, 2021 - Elsevier
Abstract Objective Randomized clinical trials (RCTs) examining the effects of resveratrol
supplementation on liver enzymes in non-alcoholic fatty liver disease (NAFLD) have …
supplementation on liver enzymes in non-alcoholic fatty liver disease (NAFLD) have …
[PDF][PDF] Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis.
A Elgebaly, IAI Radwan, MM AboElnas… - … of gastrointestinal & …, 2017 - academia.edu
Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials
S Rafiee, H Mohammadi, A Ghavami, E Sadeghi… - … therapies in clinical …, 2021 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …
[HTML][HTML] Effects of resveratrol supplementation in patients with non-alcoholic fatty liver disease—a meta-analysis
K Jakubczyk, K Skonieczna-Żydecka, J Kałduńska… - Nutrients, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is regarded as one of the most common liver
pathologies in many societies. Resveratrol, as a phenolic compound with powerful …
pathologies in many societies. Resveratrol, as a phenolic compound with powerful …
[HTML][HTML] Efficacy of resveratrol supplementation against non-alcoholic fatty liver disease: a meta-analysis of placebo-controlled clinical trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLoS …, 2016 - journals.plos.org
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
[HTML][HTML] Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
X He, Y Li, X Deng, X Xiao, J Zeng - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: Resveratrol, a polyphenol found in various plants, is known for its diverse
bioactivities and has been explored in relation to nonalcoholic fatty liver disease (NAFLD) …
bioactivities and has been explored in relation to nonalcoholic fatty liver disease (NAFLD) …
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
S Heebøll, M Kreuzfeldt, S Hamilton-Dutoit… - Scandinavian journal …, 2016 - Taylor & Francis
Objective “The obesity epidemic” has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - Nutrition research, 2014 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …
No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease
Introduction: Cardiovascular disease (CVD) accounts as a major cause of mortality among
patients with nonalcoholic fatty liver disease (NAFLD). Resveratrol, a natural polyphenol …
patients with nonalcoholic fatty liver disease (NAFLD). Resveratrol, a natural polyphenol …
[HTML][HTML] Effects of pharmacologic dose of resveratrol supplementation on oxidative/antioxidative status biomarkers in nonalcoholic fatty liver disease patients: a …
Purpose: Despite a proposed role for oxidative stress in the pathogenesis of nonalcoholic
fatty liver disease (NAFLD), antioxidant approaches have not been sufficiently investigated …
fatty liver disease (NAFLD), antioxidant approaches have not been sufficiently investigated …